Regeneron and Sanofi collaborate to jointly develop certain fully-human monoclonal antibody therapies under a global collaboration agreement. Regeneron is a leading biotechnology company that that invents life-transforming medicines for serious diseases. Sanofi is a global biopharmaceutical company focused on human health. For more information, visit www.Regeneron.com and www.Sanofi.com.